The Molecular Taxonomy of Primary Prostate CancerAdam Abeshouse, Yu Chen, Thomas Bauer et al.|Cell|2015Cited by 3.3k
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancerSircar Kanishka, Jeremy A. Squire, Maisa Yoshimoto et al.|The Journal of Pathology|2009Cited by 210
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsWilliam R. Fair, Victor E. Reuter, Michael S. Cookson et al.|Urology|1997Cited by 88
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease ProgressionKhalil Choucair, Jacques Lapointe, Karl‐Philippe Guérard et al.|Translational Oncology|2012Cited by 39
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk menEmma Killick, Hardev Pandha, Richard Morgan et al.|Scientific Reports|2013Cited by 35